A delegation from UMass Chan Medical School, Massachusetts’s first and only public academic health sciences center, recently visited Dubai Health, solidifying a new chapter in healthcare collaboration between the two organizations. The visit, marked by the signing of a Memorandum of Understanding (MOU), granted the delegation the opportunity to gain insight into Dubai’s first integrated academic health system, laying the groundwork for a productive partnership.

Inspired by UMass Chan’s reputation for impact through collaborative endeavour and aspiration to change the course of the history of disease, the partnership reflects a shared vision between the two academic health systems to advance health. Under the agreement, UMass Chan and Dubai Health will establish mutually beneficial research projects to improve patient care, create an exchange framework for learners between the two academic institutions, and drive transformative advancements for public health, both locally and globally.

Led by Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor at UMass Chan, the visit also included an opportunity for Dubai Health learners to gain insight into elective and residency program opportunities at UMass Chan.

Commenting on the partnership, Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of MBRU, stated, “This collaboration presents an exciting opportunity to combine the strengths of two academic health organizations. By pooling our resources, capabilities, and expertise, we are well-positioned to advance the frontier of medical knowledge that better serves our communities. The visit has been incredibly productive, laying the foundation for meaningful collaboration anchored in our shared purpose of advancing health for humanity.”

Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor of UMass Chan commented “It is a privilege, along with a group of senior colleagues, to learn more about the breadth and depth of activity taking place at Dubai Health and to forge closer relationships with its leadership. The signing of an MOU between our respective institutions is an exciting development and provides UMass Chan and Dubai Health with a framework from which to pursue meaningful collaborations and exchanges, by partnering, we do hope to advance together on behalf of the communities that we serve.”

The UMass Chan delegation included Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor; Terence R. Flotte, MD, Provost, Dean, and Executive Deputy Chancellor; David D. McManus, MD, Chair, Department of Medicine; Anne Larkin, MD, Associate Professor of Surgery, Vice Provost, and Senior Associate Dean for Educational Affairs; Lisa Colombo, DNP, MHA, RN, Executive Vice Chancellor and CEO, ForHealth Consulting; Rebekah Diamond, JD, Executive Director, Business Strategy & Operational Excellence, ForHealth Consulting; Brendan Chisholm, Vice Chancellor of Management, Chief of Staff, Office of the Chancellor.

For the first time in the UAE, the Emirates Society of Haematology (ESH), supported by Dubai Health, joined forces with the George Washington University to present the Emirates Hematology Best Practices Updates. The event was held last month and offered a thorough review course covering a wide range of topics in both benign and malignant hematology.

Distinguished speakers from top institutions delivered a series of engaging lectures and posed review board questions covering a wide spectrum of topics, including platelet and bleeding disorders, hematologic complications during pregnancy, bone marrow transplants and more. Each day, participants engaged in audience response questions and dynamic case discussions across various domains of hematology-oncology, fostering interactive and enriching learning experiences.

Dr. Asma Sultan Alolama, Program Director of the Adult Hematology Fellowship program at Dubai Health, President of ESH and Consultant Hematologist at Dubai Hospital, expressed her pride in achieving the establishment of this Best Practice Update for the UAE within an impressive timeframe of just three months. “Drawing more than 100 participants not only from the UAE but also from other GCC countries, this event stands as a significant milestone for the country and the wider region, representing the first instance of George Washington University convening course outside the USA.”

As Dubai’s first integrated academic health system, Dubai Health aims to contribute towards Dubai's pursuit of a sustainable, knowledge-based economy, supporting the growth and performance of the health sector.

Nine scientists from Dubai Health have been recognized in Stanford University’s 2024 list of the top 2% of scientists worldwide. This recognition marks the third straight year that faculty members from Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), which leads the Learning and Discovery missions of Dubai Health, have been honored for their continued contribution to international research.  

This year’s honorees include: Professor Nandu Goswami, Professor of Physiology at the College of Medicine; Professor Momen Atieh, Chair of Oral Diagnostics and Surgical Sciences at Hamdan Bin Mohammed College of Dental Medicine; Professor Keyvan Moharamzadeh, Associate Dean of Education at Hamdan Bin Mohammed College of Dental Medicine; Professor Samuel Ho, Professor of Medicine at the College of Medicine; Professor Thomas Adrian, Professor of Physiology at the College of Medicine; Professor Jeyaseelan Lakshmanan, Professor of Biostatistics at the College of Medicine; Dr. Ahmad Abou Tayoun, Associate Professor of Genetics; Dr. Mohammed Uddin, Associate Professor of Human Genetics; and Professor Stefan Du Plessis, Dean of Research and Graduate Studies. 

Professor Alawi Alsheikh-Ali, Provost of MBRU and Chief Academic Officer of Dubai Health, said: “This recognition is a reflection of the dedication and hard work of our scientists and Dubai Health's commitment to advancing medical research. At MBRU, our faculty members are not only educators but also innovators who continue to push the boundaries of knowledge in service of better health outcomes. We are honored by this acknowledgment and remain dedicated to aligning our academic efforts directly with the needs of our patients and the community.” 

The recognition reinforces Dubai Health's commitment to advancing research excellence in healthcare and academia, positioning its faculty as leaders in their respective fields. 

Data-driven insights 

The World’s Top 2% Scientist Rankings by Stanford University is a prestigious annual list that recognizes the most cited researchers across various scientific disciplines globally. Based on data from ‘Scopus’, the rankings reflect scientific impact through citation metrics, highlighting individuals who have made significant contributions to their fields. The researchers are categorized based on the specific disciplines they helped enrich, and the rankings also serve as a measure of influence within the academic and scientific community worldwide.